Redhill Biopharma
RDHL
#10470
Rank
โ‚ฌ3.31 M
Marketcap
0,99ย โ‚ฌ
Share price
-3.07%
Change (1 day)
-85.89%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): -705,09ย โ‚ฌ

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -595,84ย โ‚ฌ. In 2017 the company made an earnings per share (EPS) of -2.128ย โ‚ฌ a decrease over its 2016 EPS that were of -1.873ย โ‚ฌ.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-705,09ย โ‚ฌ
2017-2.128ย โ‚ฌ13.64%
2016-1.873ย โ‚ฌ9.12%
2015-1.716ย โ‚ฌ68.01%
2014-1.021ย โ‚ฌ-25.93%
2013-1.379ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
3,15ย โ‚ฌ-100.53%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
6,46ย โ‚ฌ-101.08%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
3,06ย โ‚ฌ-100.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Taro Pharmaceutical
TARO
1,04ย โ‚ฌ-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Teva Pharmaceutical Industries
TEVA
0,54ย โ‚ฌ-100.09%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel